Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00699218 · ClinicalTrials.gov registry record · NA
A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00699218 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 15 participants.
The verdict
NCT00699218, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a pilot project to study if repetitive Transcranial Magnetic Stimulation (rTMS) will benefit patients with bipolar depression safely. Based on published studies, this study hypothesizes that rTMS on the left dorsal prefrontal lobe will improve symptoms in some patients who have failed at least two medications.
Interventions
- DEVICE Magnetic Stimulator Rapid2 made by Magstim Company Ltd. U.K.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00699218
The ClinicalTrials.gov registry entry for NCT00699218 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Stimulator Rapid2 made by Magstim Company Ltd. U.K. is the first listed.
NCT00699218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00699218 about?
NCT00699218 is a clinical study titled "A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression". This is a pilot project to study if repetitive Transcranial Magnetic Stimulation (rTMS) will benefit patients with bipolar depression safely. Based on published studies, this study hypothesizes that rTMS on the left dorsal prefrontal lobe will improve symptoms in some patients who have failed at lea...
What is the current status of trial NCT00699218?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2008-05. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00699218?
The interventions under investigation include: Magnetic Stimulator Rapid2 made by Magstim Company Ltd. U.K. (DEVICE).
Who is sponsoring clinical trial NCT00699218?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.